Cocaine induced convulsions: Pharmacological antagonism at serotonergic, muscarinic and sigma receptors

Psychopharmacology

Volumn 129, Issue 4, 1997, Pages 299-310

  Ritz, Mary C ^a   George, Frank R ^a  

^a Amethyst Technologies Inc   (United States)

Author keywords

Cocaine; Convulsions; Dopamine; Muscarinic; Norepinephrine; Serotonin; Sigma

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATROPINE; BEMESETRON; CINANSERIN; COCAINE; FLUOXETINE; KETANSERIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; N ALLYLNORMETAZOCINE; NEUROTRANSMITTER; PIRENPERONE; PIRENZEPINE; PRAZOSIN; PROPRANOLOL; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; SPIPERONE; UNCLASSIFIED DRUG; YOHIMBINE; ZACOPRIDE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTONINERGIC TRANSMISSION; STEREOISOMERISM; STEREOSPECIFICITY;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, MUSCARINIC; RECEPTORS, SEROTONIN; RECEPTORS, SIGMA; SEIZURES;

EID: 0031043359     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050197     Document Type: Article

References (70)

1. Allredge BK, Lowenstein DH, Simon RP (1989) Seizures associated with recreational drug abuse. Neurology 39:1037-1039
2. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:399-412
3. Bose J (1902) Cocaine intoxication and its demoralizing effects. BMJ 2:1020-1022
4. 1A receptors on neurones of rat midbrain tegmentum. Brain Res 556:259-266
5. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membrane Biochem 7:87-106
6. Chong-Kwong M, Lipton RB (1989) Seizures in hospitalized cocaine users. Neurology 39:425-427
7. Colpaert FC, Niemegeers JE, Janssen PAJ (1982) A drug discrimination analyses of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206-214
8. Conway EE, Mezey AP, Powers K (1990) Status epilepticus following the oral ingestion of cocaine in an infant. Pediatr Emerg Care 6:189-190
9. Davies MF, Deisz RA, Prince DA, Peroutka SJ (1987) Two distinct effects of 5-hydroxytryptamine on single cortical nerons. Brain Res 423:34-352
10. Derlet RW, Albertson TE (1990a) Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors. Pharmacol Biochem Behav 36:225-231
11. Derlet RW, Albertson TE (1990b) Anticonvulsant modification of cocaine-induced toxicity in the rat. Neuropharmacology 29:255-259
12. Derlet RW, Albertson TE, Rice P (1990) Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 36:745-749
13. Dorje F, Wess J, Lambracht G, Tacke R, Mutschler E, Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256: 727-733
14. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880-887
15. 4) positive coupled with adenylate cyclase in the brain. In: Abstracts of the International Symposium on serotonin: from cell biology to pharmacology and therapeutics
16. Eidelberg E, Lesse H, Gault FP (1963) An experimental model of temporal lobe epilepsy. Studies of the convulsant properties of cocaine. In: Glaser GH (ed) EEG and behavior. Basic Books, New York, pp 277-283
17. Farrar HC, Kearns GL (1989) Cocaine: clinical pharmacology and toxicology. J Pedriatr 115:665-675
18. Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD (1994) Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol Pharmacol 46:1028-1035
19. Flynn DD, Vaishnav A.A, Mash DC (1992) Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41:736-742
20. Fozard JR (1984) MDL 7222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36-44
21. Gellman RL, Aghajanian G (1994) Serotonin2 receptor-mediated excitation of interneurons in pyriform cortex: antagonism by atypical antipsychotic drugs. Neuroscience 58:515-525
22. Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE (1989) Behavioural studies with anxiolytic drugs VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809-817
23. 2 antagonists. Eur J Pharmacol 91: 189-196
24. 2-receptor antagonist. Drug Dev Res 15:389-404
25. Jackson HC, Ball DM, Nutt DJ (1990) Noradrenergic mechanisms appear not to be involved in cocaine-induced seizures and lethality. Life Sci 47: 353-359
26. Jonsson S, O'Meara M, Young J (1983) Acute cocaine poisoning, importance of treating seizures and acidosis. Am J Med 75: 1061-1064
27. Junien JL, Leonard BE (1989) Drugs acting on sigma and phencyclidine receptors. A review of their nature, function, and possible therapeutic importance. Clin Neuropharmacol 12: 353-374
28. 3H] acetylcholine release from rat hippocampal slices. Eur J Pharmacol 200: 343-345
29. Kennedy LT, Hanbauer I (1983) Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem 41:172-178
30. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238: 739-748
31. Lemberger L, Row H, Carmichael R, Oldham S, Horng JS, Bymaster FP, Wong DT (1978a) Pharmacologic effects in man of a specific serotonin-reuptake inhibitor. Science 199: 436-437
32. Lemberger L, Row H, Carmichael R, Crabtree R, Horng JS, Bymaster FP, Wong DT (1978b) Fluoxetine, a selective serotonin uptake inhibitor. Clin Pharmacol Ther 23:421-429
33. 2 receptor binding sites. Mol Pharmacol 21:301
34. 3H]spiperone binding to rat brain regions. Proc Natl Acad Sci USA 78:2620-2624
35. Lowenstein DH, Bassa SM, Rowbotham MC, Collins SD, Mckinney HE, Simon RP (1987) Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83:841-846
36. 3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
37. 3H] 2B-carbomethoxy-3B-(4-fluorophenyl) tropane. Mol Pharmacol 36: 518-524
38. 2A receptor antagonist. Eur J Pharmacol 259:137-141
39. Matsuno K, Matsunaga K, Senda T, Mita S (1992) Increase of extracellular acetylcholine level in rat frontal cortex induced by (+) N-allynormetazocine as measured by brain micordialysis. Brain Res 575:315-319
40. Matsuno K, Matsunaga K, Senda T, Mita S (1993) Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 265:851-859
41. 2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence. Brain Res 627:49-54
42. 2 receptors in the rat brain. Neuroscience 54:701-717
43. Myers JA, Earnest MP (1984) Generalized seizures and cocaine abuse. Neurology 34:675-676
44. Pan ZZ, Colmers WF, Williams JT (1989) 5-HT mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission. J Neurophysiol 62:481-486
45. Pascual-Leone A, Dhuna A, Altafullah I, Anderson DC (1990) Cocaine-induced seizures. Neurology 40:404-407
46. Peroutka SJ (1990) 5-Hydroxytryptamine receptor subtypes. Pharmacol Toxicol 67:373-383
47. Pulay E (1922) Cocaine poisoning. JAMA 78:1855
48. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol 186:327-330
49. 3H]cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600-606
50. Ritchie JM, Greene NM (1985) Local anesthetics. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. McMillan, New York, pp 302-321
51. Ritz MC, George FR (1993) Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 264:1333-1343
52. Ritz MC, George FR (1997) Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology 129:311-321
53. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
54. Russo C, Marchi M, Andrioli GC, Cavazzina P, Raiteri. M (1993) Enhancement of glycine release from human cortex synaptosomes by acetylcholine acting at M4 Muscarinic receptors. J Pharmacol Exp Ther 266:142-146
55. Schmidt AW, Peroutka SJ (1989) 5-Hydroxytryptamine receptor "families". FASEB J 3:2242-2249
56. Sharkey J, Glen KA, Wolfe S, Kuhar MJ (1988a) Cocaine binding at sigma receptors. Eur J Pharmacol 149:171-174
57. Sharkey J, Ritz MC, Schendon JA, Hanson RC, Kuhar MJ (1988b) Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246:1048-1052
58. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmiedeberg's Arch Pharmacol 329:227-235
59. Siniscalchi A, Cristofori P, Veratti E (1987) Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 336:425-429
60. Spivey WH, Euerle B (1990) Neurologic complications of cocaine abuse. Ann Emerg Med 19:1422-1428
61. Steinberg D (1988) PROBIT: a supplementary module for SYSTAT and SYSGRAPH. SYSTAT, Evanston, Ill.
62. Steiner W, Fontaine R (1986) Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 21:1067-1071
63. Stevens DR, McCarley RW, Greene RW (1992) Serotonin-1 and serotonin-2 receptors hyperpolarize and depolarize separate populations of medial pontine reticular formation neurons in vitro. Neuroscience 47:545-553
64. 3H] haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618-5621
65. Ware MR, Stewart RB (1989) Seizures associated with fluoxetine therapy. DICP Ann Pharmacother 23:428
66. Wernicke JF (1985) The side effect profile and safety of fluoxetine. J Clin Psychiatry 46:59-67
67. Wetli CV, Mittleman RE (1981) The "body packer syndrome" toxicity following ingestion of illicit drugs packaged for transportation. J Forens Sci 26:492-500
68. Wilkinson L, Hill MA, Vang E (1992) SYSTAT: statistics, version 5.2 edition. SYSTAT. Evanston, Ill., p 724
69. Witkin JM, Menkel TM, Hickey P, Pontecorvo M, Ferkany J, Katz JL (1993) Effects of the selective sigma receptor ligand, 6-[6-(4-Hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 116377), on behavioral and toxic effects of cocaine. J Pharmacol Exp Ther 266:473-482
70. Zetterstrom QPT, Fillenz M (1989) Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 28: 1061-1066